middle.news
Tissue Repair Nears FDA Submission with 100 Patients Randomised and Strong Cash
9:28am on Friday 31st of July, 2026 AEST
•
Healthcare
Read Story
Tissue Repair Nears FDA Submission with 100 Patients Randomised and Strong Cash
9:28am on Friday 31st of July, 2026 AEST
Key Points
100 patients randomised in US Phase III trial
FDA 510(k) submission on track for October 2026
Potential US reimbursement of US$1,270 per 10g tube
First GMP production of TR Pro+ completed in Australia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tissue Repair (ASX:TRP)
OPEN ARTICLE